Mabanta, Prince Dave H.

HRN: 28-69-65  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2026
CEFTRIAXONE 1G (VIAL)
03/15/2026
03/22/2026
IV
1G
Q12H
LACERATED WOUND RIGHT PATELLAR AREA
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: